Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.

Khine HW, Teiber JF, Haley RW, Khera A, Ayers CR, Rohatgi A.

Atherosclerosis. 2017 Aug;263:156-162. doi: 10.1016/j.atherosclerosis.2017.06.007. Epub 2017 Jun 3.

PMID:
28645072
2.

Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome.

Foroozanfard F, Soleimani A, Arbab E, Samimi M, Tamadon MR.

J Nephropathol. 2017 Jan;6(1):15-24. doi: 10.15171/jnp.2017.04. Epub 2016 Aug 8.

3.

APO A2 -265T/C Polymorphism Is Associated with Increased Inflammatory Responses in Patients with Type 2 Diabetes Mellitus.

Koohdani F, Sadrzadeh-Yeganeh H, Djalali M, Eshraghian M, Zamani E, Sotoudeh G, Mansournia MA, Keramat L.

Diabetes Metab J. 2016 Jun;40(3):222-9. doi: 10.4093/dmj.2016.40.3.222.

4.

Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity.

Jones MR, Brower MA, Xu N, Cui J, Mengesha E, Chen YD, Taylor KD, Azziz R, Goodarzi MO.

PLoS Genet. 2015 Aug 25;11(8):e1005455. doi: 10.1371/journal.pgen.1005455. eCollection 2015 Aug.

5.

The role of adipose tissue in insulin resistance in women of African ancestry.

Goedecke JH, Levitt NS, Evans J, Ellman N, Hume DJ, Kotze L, Tootla M, Victor H, Keswell D.

J Obes. 2013;2013:952916. doi: 10.1155/2013/952916. Epub 2013 Jan 14. Review.

6.

Racial differences in association of elevated interleukin-18 levels with type 2 diabetes: the Atherosclerosis Risk in Communities study.

Negi SI, Pankow JS, Fernstrom K, Hoogeveen RC, Zhu N, Couper D, Schmidt MI, Duncan BB, Ballantyne CM.

Diabetes Care. 2012 Jul;35(7):1513-8. doi: 10.2337/dc11-1957. Epub 2012 May 17.

7.

Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery.

Gui T, Shimokado A, Sun Y, Akasaka T, Muragaki Y.

Mediators Inflamm. 2012;2012:693083. doi: 10.1155/2012/693083. Epub 2012 Apr 11. Review.

8.

Is PCOS an inflammatory process?

Duleba AJ, Dokras A.

Fertil Steril. 2012 Jan;97(1):7-12. doi: 10.1016/j.fertnstert.2011.11.023.

9.

Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study.

Chen LQ, Rohatgi A, Ayers CR, Das SR, Khera A, Berry JD, McGuire DK, de Lemos JA.

Atherosclerosis. 2011 Dec;219(2):833-8. doi: 10.1016/j.atherosclerosis.2011.08.029. Epub 2011 Aug 22.

10.

Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart Study.

Nguyen AB, Rohatgi A, Garcia CK, Ayers CR, Das SR, Lakoski SG, Berry JD, Khera A, McGuire DK, de Lemos JA.

Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2136-43. doi: 10.1161/ATVBAHA.111.228692. Epub 2011 Aug 4.

11.

Lean body mass, interleukin 18, and metabolic syndrome in apparently healthy Chinese.

Sun L, Hu FB, Yu Z, Li H, Liu H, Wang X, Yu D, Wu H, Zhang G, Zong G, Liu Y, Lin X.

PLoS One. 2011 Mar 18;6(3):e18104. doi: 10.1371/journal.pone.0018104.

12.

Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss.

Moschen AR, Molnar C, Enrich B, Geiger S, Ebenbichler CF, Tilg H.

Mol Med. 2011;17(7-8):840-5. doi: 10.2119/molmed.2010.00108. Epub 2011 Mar 2.

13.

Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome.

Yamaoka-Tojo M, Tojo T, Wakaume K, Kameda R, Nemoto S, Takahira N, Masuda T, Izumi T.

Nutr Metab (Lond). 2011 Jan 20;8:3. doi: 10.1186/1743-7075-8-3.

14.

Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome.

Beavers KM, Nicklas BJ.

Front Biosci (Schol Ed). 2011 Jan 1;3:168-77. Review.

15.

The role of interleukin-18 in the metabolic syndrome.

Trøseid M, Seljeflot I, Arnesen H.

Cardiovasc Diabetol. 2010 Mar 23;9:11. doi: 10.1186/1475-2840-9-11. Review.

16.

Circulating levels of interleukin-1 family cytokines in overweight adolescents.

Jung C, Gerdes N, Fritzenwanger M, Figulla HR.

Mediators Inflamm. 2010;2010:958403. doi: 10.1155/2010/958403. Epub 2010 Feb 9.

17.

Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule.

Rohatgi A, Owens AW, Khera A, Ayers CR, Banks K, Das SR, Berry JD, McGuire DK, de Lemos JA.

Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1684-90. doi: 10.1161/ATVBAHA.109.190553.

18.

Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions.

Barrey E, Mucher E, Jeansoule N, Larcher T, Guigand L, Herszberg B, Chaffaux S, Guérin G, Mata X, Benech P, Canale M, Alibert O, Maltere P, Gidrol X.

BMC Vet Res. 2009 Aug 7;5:29. doi: 10.1186/1746-6148-5-29.

19.

Sex differences in the relationship between C-reactive protein and body fat.

Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM, de Lemos JA.

J Clin Endocrinol Metab. 2009 Sep;94(9):3251-8. doi: 10.1210/jc.2008-2406. Epub 2009 Jun 30.

20.

Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.

Tsimikas S, Clopton P, Brilakis ES, Marcovina SM, Khera A, Miller ER, de Lemos JA, Witztum JL.

Circulation. 2009 Apr 7;119(13):1711-9. doi: 10.1161/CIRCULATIONAHA.108.836940. Epub 2009 Mar 23.

Supplemental Content

Support Center